cough Archives -

Digital/ News/ News

After cough drug setback, Merck partners Hyfe’s tracking app

Phil Taylor cough, digital, digital health, gefapixant, Hyfe, Merck & Co, partnering, Pfizer, ResApp Health 0 Comment

Merck & Co has signed a deal with digital health firm Hyfe that will see its cough-detecting smartphone

After cough drug setback, Merck partners Hyfe’s tracking app

https://pharmaphorum.com/news/after-cough-drug-setback-merck-partners-hyfes-tracking-app/

News/ News/ R&D

Bayer’s pipeline takes a hit as it drops eliapixant

Phil Taylor Bayer, Bellus Health, cough, eliapixant, gefapixant, Merck & Co 0 Comment

Bayer has abandoned development of its investigational P2X3 receptor antagonist eliapixant, despite promising efficacy data in clinical trials,

Bayer’s pipeline takes a hit as it drops eliapixant

https://pharmaphorum.com/news/bayers-pipeline-takes-a-hit-as-it-drops-eliapixant/

Market Access/ News/ News

FDA stifles Merck’s cough drug gefapixant, asking for more data

Phil Taylor Bayer, Bellus Health, cough, eliapixant, fda, gefapixant, Merck & Co 0 Comment

The FDA has issued a complete response letter (CRL) to Merck & Co’s gefapixant candidate for refractory chronic

FDA stifles Merck’s cough drug gefapixant, asking for more data

https://pharmaphorum.com/news/fda-stifles-mercks-cough-drug-gefapixant-asking-for-more-data/

News/ News/ R&D

Bayer’s eliapixant hits the right notes in PAGANINI cough study

Phil Taylor Bayer, Bellus Health, cough, eliapixant, gefapixant, Merck & Co 0 Comment

Bayer has released the data in its phase 2b trial of eliapixant in refractory chronic cough, as it

Bayer’s eliapixant hits the right notes in PAGANINI cough study

https://pharmaphorum.com/news/bayers-eliapixant-hits-the-right-notes-in-paganini-cough-study/

News/ News/ R&D

Chasing Merck & Co, Bayer builds case for cough drug eliapixant

Phil Taylor Bayer, Bellus Health, cough, eliapixant, gefapixant, Merck & Co 0 Comment

Bayer says its drug candidate for chronic cough – eliapixant – has hit the mark in a phase

Chasing Merck & Co, Bayer builds case for cough drug eliapixant

https://pharmaphorum.com/news/chasing-merck-bayer-builds-case-for-cough-drug-eliapixant/

Digital/ News/ News

COVID cough app Hyfe launches in UK and Ireland

Phil Taylor app, coronavirus, cough, COVID-19, digital, digital health, Hyfe, respiratory 0 Comment

A smartphone app that uses artificial intelligence to assess the sound of coughing has been launched in the

COVID cough app Hyfe launches in UK and Ireland

https://pharmaphorum.com/news/covid-cough-app-hyfe-launches-in-uk-and-ireland/

Digital/ News/ News/ Top stories

Does my cough sound like COVID? There could be an app for that

Phil Taylor artificial intelligence, coronavirus, cough, COVID-19, digital, machine learning 0 Comment

It could be possible to detect whether someone has COVID-19 or not, just from the sound of their

Does my cough sound like COVID? There could be an app for that

https://pharmaphorum.com/news/does-my-cough-sound-like-covid-there-could-be-an-app-for-that/

News/ News/ R&D

Merck & Co plans to file cough drug gefapixant after phase 3 success

Richard Staines cough, Merck & Co, R&D, respiratory 0 Comment

Merck & Co is planning to file a drug for unexplained or treatment-resistant cough after supportive results from

Merck & Co plans to file cough drug gefapixant after phase 3 success

https://pharmaphorum.com/news/merck-co-plans-to-file-cough-drug-gefapixant-after-phase-3-success/

News/ News/ R&D

Merck’s chronic cough drug gefapixant clears phase 3 test

Phil Taylor cough, gefapixant, Merck & Co 0 Comment

Merck & Co/MSD’s experimental drug gefapixant has improved the frequency of coughing in a pair of phase 3

Merck’s chronic cough drug gefapixant clears phase 3 test

https://pharmaphorum.com/news/mercks-chronic-cough-drug-gefapixant-clears-phase-3-test/

Trending

cough

Login